ArticleACR open rheumatology2020

Recombinant Soluble TNF-α Receptor Fusion Protein Therapy Reduces Insulin Resistance in Non-Diabetic Active Rheumatoid Arthritis Patients.

Chrong-Reen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.